Literature DB >> 16798787

Non-invasive measurement of reduced ventilation:perfusion ratio and shunt in infants with bronchopulmonary dysplasia: a physiological definition of the disease.

D Quine1, C M Wong, E M Boyle, J G Jones, B J Stenson.   

Abstract

BACKGROUND: An objective definition of bronchopulmonary dysplasia (BPD) is required to interpret trial outcomes and provide a baseline for prognostic studies. Current definitions do not quantify disease severity. The cardinal measures of impaired gas exchange are a reduced ventilation:perfusion ratio (V(A):Q) and increased right to left shunt. These can be determined non-invasively by plotting arterial oxygen saturation (Spo(2)) against inspired oxygen pressure (PIo(2)). AIMS: To describe the reduced V(A):Q and shunt in infants with BPD and evaluate these as graded measures of pulmonary dysfunction.
METHODS: 21 preterm infants with BPD were studied. PIo(2) was changed stepwise to vary Spo(2) between 86% and 94%. Pairs of PIo(2) and Spo(2) data points for each infant were plotted and analysed to derive reduced V(A):Q ratio and shunt.
RESULTS: In every infant, the Spo(2) versus PIo(2) curve was shifted to the right of the normal because of a reduced V(A):Q. The mean (SD) shift was 16.5 (4.7) kPa (normal 6 kPa). Varying degrees of shunt were also present, but these were less important in determining Spo(2) within the studied range. The degree of shift was strongly predictive of the PIo(2) required to achieve any Spo(2) within the range 86-94% (R(2)>0.9), permitting shift and V(A):Q to be determined from a single pair of PIo(2) and SpO(2) values in this range.
CONCLUSIONS: The predominant gas exchange impairment in BPD is a reduced V(A):Q, described by the right shift of the Spo(2) versus PIo(2) relationship. This provides a simpler method for defining BPD, which can grade disease severity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798787      PMCID: PMC2672753          DOI: 10.1136/adc.2006.095406

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  19 in total

1.  Variability in the use of supplemental oxygen for bronchopulmonary dysplasia.

Authors:  Dan L Ellsbury; Michael J Acarregui; Gail A McGuinness; Jonathan M Klein
Journal:  J Pediatr       Date:  2002-02       Impact factor: 4.406

2.  Bronchopulmonary dysplasia.

Authors:  A H Jobe; E Bancalari
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

Review 3.  Pathology of new bronchopulmonary dysplasia.

Authors:  Jacqueline J Coalson
Journal:  Semin Neonatol       Date:  2003-02

4.  Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period.

Authors:  A T Shennan; M S Dunn; A Ohlsson; K Lennox; E M Hoskins
Journal:  Pediatrics       Date:  1988-10       Impact factor: 7.124

5.  Accurate determination of O2 dissociation curve of human blood above 98.7 percent saturation with data on O2 solubility in unmodified human blood from 0 degrees to 37 degrees C.

Authors:  F J Roughton; J W Severinghaus
Journal:  J Appl Physiol       Date:  1973-12       Impact factor: 3.531

6.  Discriminating between the effect of shunt and reduced VA/Q on arterial oxygen saturation is particularly useful in clinical practice.

Authors:  J G Jones; S E Jones
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

7.  Accuracy and precision of fourteen pulse oximeters.

Authors:  B Hannhart; J P Haberer; C Saunier; M C Laxenaire
Journal:  Eur Respir J       Date:  1991-01       Impact factor: 16.671

8.  Is chronic lung disease in low birth weight infants preventable? A survey of eight centers.

Authors:  M E Avery; W H Tooley; J B Keller; S S Hurd; M H Bryan; R B Cotton; M F Epstein; P M Fitzhardinge; C B Hansen; T N Hansen
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

9.  Non-invasive estimation of shunt and ventilation-perfusion mismatch.

Authors:  Søren Kjaergaard; Stephen Rees; Jerzy Malczynski; Jørgen Ahrenkiel Nielsen; Per Thorgaard; Egon Toft; Steen Andreassen
Journal:  Intensive Care Med       Date:  2003-04-16       Impact factor: 17.440

10.  Analysis of factors which affect the relationship between inspired oxygen partial pressure and arterial oxygen saturation.

Authors:  P G Roe; J G Jones
Journal:  Br J Anaesth       Date:  1993-10       Impact factor: 9.166

View more
  7 in total

1.  Evaluation of a computer program for non-invasive determination of pulmonary shunt and ventilation-perfusion mismatch.

Authors:  Geoffrey G Lockwood; Nick L S Fung; J Gareth Jones
Journal:  J Clin Monit Comput       Date:  2014-01-09       Impact factor: 2.502

2.  Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study.

Authors:  Joseph Fawke; Sooky Lum; Jane Kirkby; Enid Hennessy; Neil Marlow; Victoria Rowell; Sue Thomas; Janet Stocks
Journal:  Am J Respir Crit Care Med       Date:  2010-04-08       Impact factor: 21.405

3.  Reliability of a Noninvasive Measure of V./Q. Mismatch for Bronchopulmonary Dysplasia.

Authors:  Nicolas Bamat; Sarvin Ghavam; Yumei Liu; Sara B DeMauro; Erik A Jensen; Robin Roberts; Bradley A Yoder; Haresh Kirpalani
Journal:  Ann Am Thorac Soc       Date:  2015-05

4.  Ventilation/perfusion ratio and right to left shunt in healthy newborn infants.

Authors:  Theodore Dassios; Kamal Ali; Thomas Rossor; Anne Greenough
Journal:  J Clin Monit Comput       Date:  2016-12-23       Impact factor: 2.502

5.  AZTEC-azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes.

Authors:  Tin Man Mandy Lau; John Lowe; Timothy Pickles; Kerenza Hood; Sailesh Kotecha; David Gillespie
Journal:  Trials       Date:  2022-08-23       Impact factor: 2.728

6.  Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.

Authors:  Abhijeet Rakshasbhuvankar; Sanjay Patole; Karen Simmer; J Jane Pillow
Journal:  BMC Pediatr       Date:  2017-12-16       Impact factor: 2.125

7.  Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants.

Authors:  John Lowe; David Gillespie; Marie Hubbard; Lei Zhang; Nigel Kirby; Timothy Pickles; Emma Thomas-Jones; Mark A Turner; Nigel Klein; Julian R Marchesi; Kerenza Hood; Janet Berrington; Sailesh Kotecha
Journal:  BMJ Open       Date:  2020-10-06       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.